Interventional therapies, including transarterial chemoembolization (TACE), yttrium-90 selective internal radiation therapy (90Y SIRT), and ablation ...
Hepatocellular carcinoma (HCC) represents about 80 to 90% of cases of primary liver cancer. On a global level, 905,700 new ...
Bristol Myers Squibb has won the European Commission's expanded approval of its Opdivo plus Yervoy cancer-drug combination for early use in certain patients with liver cancer. Bristol Myers on Friday ...
Although histotripsy can successfully destroy tumors in the liver, longer-term data are still needed to see recurrence rates ...
News-Medical.Net on MSN22h
Breakthrough study defines ideal interval for immunotherapy and liver transplantsHepatocellular carcinoma (HCC) represents about 80 to 90% of cases of primary liver cancer. On a global level, 905,700 new cases and 830,200 deaths were registered in 2020 according to the World ...
Liver resection is recommended to treat some types of cancer originating in the liver (hepatocellular cancer, bile duct cancer, and gallbladder cancer), and occasionally benign liver tumors that are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback